We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-1.82%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.11B
AUM Growth
-$55.5M
Cap. Flow
-$30.5M
Cap. Flow %
-2.75%
Top 10 Hldgs %
75.65%
Holding
63
New
Increased
1
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
VEEV icon
Veeva Systems
VEEV
+$145K

Top Sells

Rank Stock Value
1
ALPN
Alpine Immune Sciences Inc
ALPN
+$493K
2
MMM icon
3M
MMM
+$359K
3
CI icon
Cigna
CI
+$148K
4
FTV icon
Fortive
FTV
+$69.4K

Sector Composition

Rank Sector Weight
1 Financials 52.49%
2 Healthcare 17.62%
3 Materials 8.07%
4 Energy 7.76%
5 Technology 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
51
MetLife
MET
$61.5B
$743K 0.07%
10,580
IEX icon
52
IDEX
IEX
$17.5B
$545K 0.05%
2,710
VEEV icon
53
Veeva Systems
VEEV
$38.4B
$500K 0.05%
2,730
+730
+37% +$145K
BN icon
54
Brookfield
BN
$110B
$415K 0.04%
15,000
AVXL icon
55
Anavex Life Sciences
AVXL
$325M
$361K 0.03%
85,585
VYM icon
56
Vanguard High Dividend Yield ETF
VYM
$83.8B
$288K 0.03%
2,430
USB icon
57
US Bancorp
USB
$100B
$210K 0.02%
5,300
OCUL icon
58
Ocular Therapeutix
OCUL
$2.14B
$116K 0.01%
17,000
CRVS icon
59
Corvus Pharmaceuticals
CRVS
$1.24B
$91K 0.01%
49,959
ALDX icon
60
Aldeyra Therapeutics
ALDX
$91.1M
$66K 0.01%
20,020
ALPN
61
DELISTED
Alpine Immune Sciences Inc
ALPN
-12,445
Closed -$493K

Similar funds

Hikari Power's Q2 2024 Portfolio in Review

As of Q2 2024, Hikari Power held 63 positions worth $1.11B, down 4.8% from $1.16B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 1.6%. Hikari Power opened no new positions and exited 1, leaving the 63-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 52% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power added most to Veeva Systems in Q2 2024, an estimated $145K increase.
  • Hikari Power's biggest Q2 2024 reduction was 3M, cutting an estimated $359K.
  • Hikari Power fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $493K.
  • Hikari Power's ten largest holdings make up 76% of its $1.11B portfolio in Q2 2024.
  • Hikari Power opened 0 new positions and closed 1 in Q2 2024.
  • Hikari Power's portfolio value fell 4.8% quarter-over-quarter to $1.11B.

Based on Hikari Power's 13F filing for Q2 2024, filed 23 Jul 2024.